Mitochondrial Genome-Derived circRNA mc-COX2 Functions as an Oncogene in Chronic Lymphocytic Leukemia

Zijuan Wu,Handong Sun,Chunling Wang,Wenjie Liu,Ming Liu,Yanhui Zhu,Wei Xu,Hui Jin,Jianyong Li
DOI: https://doi.org/10.1016/j.omtn.2020.04.017
2020-06-01
Abstract:<p>Circular RNAs (circRNAs), a novel family of non-coding RNAs, play crucial roles in cancer progression. While the existing research focuses on nuclear genome-derived (nu)-circRNAs, the biological and clinical characteristics of mitochondrial genome-derived (mt)-circRNAs remain largely unknown, especially in chronic lymphocytic leukemia (CLL). In this study, we attempted to identify the novel characteristics of mc-COX2 (mitochondrial-genome-derived circRNAs, mc), one of the mt-circRNAs that can be involved in CLL progression. Mt-circRNAs were founded highly expressed in the plasma exosomes of CLL patients. The endogenous reduction of mc-COX2 can affect mitochondrial functions, suppress cell proliferation and induce cell apoptosis. The upregulation of mc-COX2 was positively associated with leukemogenesis and survival worsening of CLL patients. Notably, functional analysis revealed that mc-COX2 differing from conventional nu-circRNAs was less stable and may function through novel mechanisms other than acting as the competing endogenous RNA. We also screened and tested several chemical compounds and small-molecule inhibitors that can decrease the generation of mc-COX2. It was found the silencing of mc-COX2 in CLL cells strengthened the anti-tumor effects of drugs used in coordination. Our findings prove that mc-COX2, a critical mt-circRNA highly expressed in plasma, derived from CLL cells and delivered by exosomes is associated with the progression and prognosis of CLL.</p>
What problem does this paper attempt to address?